Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues.
Chilosi
M
M
Department of Pathology, University of Verona, Italy.
Doglioni
C
C
Menestrina
F
F
Lestani
M
M
Piazzola
E
E
Benedetti
A
A
Pedron
S
S
Montagna
L
L
Pizzolo
G
G
Mariuzzi
G M
GM
Janossy
G
G
D000818:Animals; D015415:Biomarkers; D002455:Cell Division; D050759:Cyclin-Dependent Kinase Inhibitor p21; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D016213:Cyclins / Q000096:biosynthesis; D004791:Enzyme Inhibitors / Q000378:metabolism*; D005109:Extracellular Matrix / Q000502:physiology*; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis*; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000503:physiopathology*; D008221:Lymphoid Tissue / Q000502:physiology / Q000503:physiopathology; D015398:Signal Transduction; D012859:Sjogren's Syndrome / Q000276:immunology / Q000503:physiopathology; D013601:T-Lymphocytes / Q000276:immunology
D015415:Biomarkers; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D004791:Enzyme Inhibitors; D016326:Extracellular Matrix Proteins; D018844:Cyclin-Dependent Kinases